96 related articles for article (PubMed ID: 19605572)
21. Additive effects of nicorandil on coronary blood flow during continuous administration of nitroglycerin.
Okamura A; Rakugi H; Ohishi M; Yanagitani Y; Shimizu M; Nishii T; Taniyama Y; Asai T; Takiuchi S; Moriguchi K; Ohkuro M; Komai N; Yamada K; Inamoto N; Otsuka A; Higaki J; Ogihara T
J Am Coll Cardiol; 2001 Mar; 37(3):719-25. PubMed ID: 11693742
[TBL] [Abstract][Full Text] [Related]
22. Active and passive coronary vasodilation after intracoronary and sublingual nitroglycerin.
Schulz W; von Anderten W; Reiber JH; Bernauer R; Kaltenbach M; Kober G
Z Kardiol; 1983; 72 Suppl 3():82-6. PubMed ID: 6421018
[TBL] [Abstract][Full Text] [Related]
23. Myocardial bridging in a man with non-ST-elevation myocardial infarction.
Bergmark BA; Galper BZ; Shah AM; Bhatt DL
Circulation; 2015 Mar; 131(11):e373-4. PubMed ID: 25779546
[No Abstract] [Full Text] [Related]
24. Oral nicorandil to reduce cardiac death after coronary revascularization in hemodialysis patients: a randomized trial.
Nishimura M; Tokoro T; Nishida M; Hashimoto T; Kobayashi H; Imai R; Yamazaki S; Okino K; Iwamoto N; Takahashi H; Ono T
Am J Kidney Dis; 2009 Aug; 54(2):307-17. PubMed ID: 19535190
[TBL] [Abstract][Full Text] [Related]
25. Dilator effects of nicorandil on isolated perfused coronary arteries of humans.
Sakaino N; Araki H; Nishi K
Arch Int Pharmacodyn Ther; 1990; 306():100-5. PubMed ID: 2150166
[TBL] [Abstract][Full Text] [Related]
26. Safety and efficacy of a novel hyperaemic agent, intracoronary nicorandil, for invasive physiological assessments in the cardiac catheterization laboratory.
Jang HJ; Koo BK; Lee HS; Park JB; Kim JH; Seo MK; Yang HM; Park KW; Nam CW; Doh JH; Kim HS
Eur Heart J; 2013 Jul; 34(27):2055-62. PubMed ID: 23396491
[TBL] [Abstract][Full Text] [Related]
27. Intracoronary nicorandil relieves multiple coronary vasospasm with hemodynamic collapse.
Hayashi T; Ichikawa M; Iwata A; Nakata T; Lim YJ; Mishima M
Circ J; 2008 Feb; 72(2):327-30. PubMed ID: 18219174
[TBL] [Abstract][Full Text] [Related]
28. Effect of nitroglycerin and nicorandil on regional poststenotic quantitative coronary blood flow in coronary artery disease: a combined digital quantitative angiographic and intracoronary doppler study.
Haager PK; Klues HG; Schmidt M; vom Dahl J; Hanrath P
J Cardiovasc Pharmacol; 1999 Jan; 33(1):126-34. PubMed ID: 9890407
[TBL] [Abstract][Full Text] [Related]
29. Effect of the new nitrate ester ITF 296 on coronary and systemic hemodynamics in the conscious dog: comparison with nitroglycerin and nicorandil.
Ueno A; Bergamaschi M; Gromo G; Nonaka K; Mizrahi J
J Cardiovasc Pharmacol; 1995; 26 Suppl 4():S13-20. PubMed ID: 8839221
[TBL] [Abstract][Full Text] [Related]
30. Effect on periprocedural myocardial infarction of intra-coronary nicorandil prior to percutaneous coronary intervention in stable and unstable angina.
Hwang J; Lee HC; Kim BW; Yang MJ; Park JS; Park JH; Lee HW; Oh J; Choi JH; Cha KS; Hong TJ; Song S; Kim SP
J Cardiol; 2013 Aug; 62(2):77-81. PubMed ID: 23731922
[TBL] [Abstract][Full Text] [Related]
31. [Effects of intra-coronary and intra-graft administration of nicorandil for coronary spasm after coronary artery bypass grafting].
Kimura N; Kawahito K; Adachi K; Murata H; Yamaguchi A; Adachi H; Ino T
Kyobu Geka; 2006 Jan; 59(1):71-7. PubMed ID: 16440689
[TBL] [Abstract][Full Text] [Related]
32. Angiographic response to a vasodilating drug, nicorandil, in patients with coronary artery disease.
Kishida H; Hata N; Kusama Y; Iwahara S; Sasaki Y; Mori N; Yasutake M; Koumi S; Takayama M; Munakata K
Jpn Heart J; 1990 Mar; 31(2):135-43. PubMed ID: 2141366
[TBL] [Abstract][Full Text] [Related]
33. Effect of myocardial protection of intracoronary adenosine and nicorandil injection in patients undergoing non-urgent percutaneous coronary intervention: a randomized controlled trial.
Kim SJ; Kim W; Woo JS; Ha SJ; Kang WY; Hwang SH; Kang DG; Lee SU; Cho SK; Im JS; Kim W
Int J Cardiol; 2012 Jun; 158(1):88-92. PubMed ID: 21256606
[TBL] [Abstract][Full Text] [Related]
34. [Effect of intracoronary and intravenous administration of propranolol on coronary vasomotility at rest and during exercise].
Bortone A; Hess OM; Gaglione A; Locuratolo N; Troito G; Rizzon P; Chiddo A
Cardiologia; 1989 Aug; 34(8):679-88. PubMed ID: 2605578
[TBL] [Abstract][Full Text] [Related]
35. [Augmentation of vessel narrowing by nitroglycerine in a case with myocardial bridge].
Durukan M; Aksu T; Çolak A; Güray Ü
Anadolu Kardiyol Derg; 2011 Aug; 11(5):464-6. PubMed ID: 21733785
[No Abstract] [Full Text] [Related]
36. Coronary vasomotion during dynamic exercise: influence of intravenous and intracoronary nicardipine.
Kaufmann P; Vassalli G; Utzinger U; Hess OM
J Am Coll Cardiol; 1995 Sep; 26(3):624-31. PubMed ID: 7642851
[TBL] [Abstract][Full Text] [Related]
37. Mechanism of relaxant effects of nicorandil on the dog coronary artery.
Imai S; Ushijima T; Nakazawa M; Nabata H; Sakai K
Arch Int Pharmacodyn Ther; 1983 Oct; 265(2):274-82. PubMed ID: 6228201
[TBL] [Abstract][Full Text] [Related]
38. Usefulness of massive oral nicorandil in a patient with variant angina refractory to conventional treatment.
Kurisu S; Inoue I; Kawagoe T; Ishihara M; Shimatani Y; Nishioka K; Nakamura S; Umemura T; Yoshida M
Intern Med; 2003 Feb; 42(2):163-7. PubMed ID: 12636235
[TBL] [Abstract][Full Text] [Related]
39. Effects of nicorandil on the conductive coronary artery of the dog.
Imai S; Nakazawa M; Takeda K; Nakagawa Y; Katano Y; Tsukada T; Nabata H; Ushijima T
J Cardiovasc Pharmacol; 1987; 10 Suppl 8():S10-6. PubMed ID: 2447415
[TBL] [Abstract][Full Text] [Related]
40. [The effect of esmolol on hemodynamic of the myocardial bridging-mural mural coronary artery].
Zhang GH; Ge JB; Qian JY; Fan B; Wang QB; Lu Y; Wang H; Feng Q
Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Feb; 33(2):158-60. PubMed ID: 15924815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
